Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.895
+0.005 (0.26%)
Aug 6, 2026, 12:51 PM EDT - Market open
Compass Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
341.27M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 850.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 123.87M |
| Century Therapeutics | 109.16M |
| Clinuvel Pharmaceuticals | 64.24M |
| Fennec Pharmaceuticals | 51.00M |
| Zentalis Pharmaceuticals | 26.87M |
| Upstream Bio | 3.32M |
| Vicore Pharma Holding AB | 370.61K |
| Lyell Immunopharma | 31.00K |
CMPX News
- 20 days ago - Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 - GlobeNewsWire
- 2 months ago - Compass Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - Compass Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 2 months ago - Compass Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 3 months ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire